ATE210677T1 - Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung - Google Patents

Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung

Info

Publication number: ATE210677T1
Authority: AT; Austria
Prior art keywords: analogues; angiotensin iii; tissue healing; wound healing; analogs
Prior art date: 1993-09-24

Application number

AT94928150T

Other languages

English (en)

Inventor

Kathleen Elizabeth Rodgers

Gere Stodder Dizerega

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-24

Filing date

1994-09-19

Publication date

2001-12-15

1994-09-19 Application filed by Univ Southern California filed Critical Univ Southern California

2001-12-15 Application granted granted Critical

2001-12-15 Publication of ATE210677T1 publication Critical patent/ATE210677T1/de

Links

QMMRCKSBBNJCMR-KMZPNFOHSA-N Angiotensin III Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)C1=CC=C(O)C=C1 QMMRCKSBBNJCMR-KMZPNFOHSA-N 0.000 title abstract 2
101800000738 Angiotensin-3 Proteins 0.000 title abstract 2
102400000348 Angiotensin-3 Human genes 0.000 title abstract 2
230000035876 healing Effects 0.000 title 1
230000029663 wound healing Effects 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
239000013543 active substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Vascular Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT94928150T 1993-09-24 1994-09-19 Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung ATE210677T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US12636893A	1993-09-24	1993-09-24
PCT/US1994/010503 WO1995008337A1 (en)	1993-09-24	1994-09-19	Use of angiotensin iii and analogs thereof in tissue repair

Publications (1)

Publication Number	Publication Date
ATE210677T1 true ATE210677T1 (de)	2001-12-15

Family

ID=22424455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94928150T ATE210677T1 (de)	1993-09-24	1994-09-19	Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung

Country Status (13)

Country	Link
US (1)	US5629292A (de)
EP (1)	EP0730465B1 (de)
JP (1)	JPH09502977A (de)
AT (1)	ATE210677T1 (de)
AU (1)	AU706333B2 (de)
CA (1)	CA2172493C (de)
DE (1)	DE69429450T2 (de)
DK (1)	DK0730465T3 (de)
ES (1)	ES2168312T3 (de)
PT (1)	PT730465E (de)
TW (1)	TW311088B (de)
WO (1)	WO1995008337A1 (de)
ZA (1)	ZA947338B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5955430A (en) *	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) *	1994-11-14	2003-03-20	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
US7112320B1 (en)	1995-06-07	2006-09-26	Andre Beaulieu	Solid wound healing formulations containing fibronectin
US6528483B2 (en)	1995-06-07	2003-03-04	André Beaulieu	Method of producing concentrated non-buffered solutions of fibronectin
MY121607A (en) *	1995-07-10	2006-02-28	Hyundai Curitel Inc	Grid moving method of object image and apparatus using the same and compaction/motion estimation method using the same and apparatus thereof
US6110895A (en) *	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
EP1410801B1 (de)	1997-01-28	2013-04-10	University Of Southern California	Verfahren zur Förderung der hämatopoietischen Zellproliferation und Differenzierung
US6335195B1 (en)	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
AU6650098A (en) *	1997-02-04	1998-08-25	University Of Southern California	Method for accelerating healing of thermal injuries
US6197751B1 (en)	1997-11-10	2001-03-06	The United States Of America As Represented By The Department Of Health And Human Services	Thymosin α1 promotes tissue repair, angiogenesis and cell migration
JP2002507383A (ja) *	1997-11-26	2002-03-12	ユニヴァースティオブサザーンカリフォルニア	造血および間葉細胞の増殖並びに分化を促進する方法
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
DE69824445T2 (de)	1997-12-12	2005-06-30	University Of Southern California, Los Angeles	Zusammensetzungen zur wundheilung
CA2319701C (en)	1998-02-09	2009-09-29	University Of Southern California	Method of promoting erythropoiesis
US6455500B1 (en)	1998-03-10	2002-09-24	University Of Southern California	Radiation therapy methods
US7173011B2 (en)	2000-11-20	2007-02-06	University Of Southern California	Radiation therapy methods
US6498138B1 (en)	1998-03-11	2002-12-24	University Of Southern California	Method of promoting production of living tissue equivalents
CA2324988A1 (en) *	1998-04-09	1999-10-21	University Of Southern California	Methods for treatment and prevention of infections
JP2003521441A (ja)	1998-05-11	2003-07-15	ユニヴァースティオブサザーンカリフォルニア	化学療法後の白血球生残率を増加させる方法
US6762167B1 (en)	1998-05-11	2004-07-13	University Of Southern California	Methods for treating a patient undergoing chemotherapy
CA2328871C (en)	1998-07-13	2002-10-01	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
US6916783B2 (en) *	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
JP2002522505A (ja)	1998-08-13	2002-07-23	ユニヴァースティオブサザーンカリフォルニア	虚血組織への血流を増加させる方法
ATE286511T1 (de) *	1999-02-17	2005-01-15	Pfizer Prod Inc	Fusionsproteine mit trägern welche eine doppelte immunantwort induzieren
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US7338938B2 (en)	1999-05-10	2008-03-04	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6821953B1 (en) *	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en)	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
EP1345602B1 (de)	2000-11-30	2010-07-21	Novodermix International Limited	Heilung von wunden
US7122523B2 (en) *	2001-05-01	2006-10-17	University Of Southern California	Methods for inhibiting tumor cell proliferation
EP2197465A2 (de) *	2007-09-11	2010-06-23	Mondobiotech Laboratories AG	Verwendung von angiotensin-ii als therapeutisches mittel bei der behandlung von infektionen mit z.b. s. pneumoniae
WO2009033820A2 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
WO2009033667A2 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
AU2008303942A1 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of BFGF 1-24 and optionally (ARG 8) vasopressin to treat eg S. pneumoniae infection
WO2009040071A2 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
US20090227507A1 (en) *	2008-03-10	2009-09-10	University Of Southern California	Angiotensin (1-7) Dosage Forms and Uses Thereof
HUE026131T2 (en) *	2008-12-29	2016-05-30	Trevena Inc	Beta-arresin effector and preparations and methods for their use
KR101514414B1 (ko)	2011-02-02	2015-05-04	유니버시티 오브 써던 캘리포니아	당뇨병성 족부 궤양의 치료방법
MX2014009233A (es)	2012-01-31	2015-05-15	Trevena Inc	Efectores de beta-arrestina y composiciones y metodos de uso de la misma.
US8557958B1 (en)	2012-06-18	2013-10-15	Tarix Pharmaceuticals Ltd.	Compositions and methods for treatment of diabetes
US8633158B1 (en)	2012-10-02	2014-01-21	Tarix Pharmaceuticals Ltd.	Angiotensin in treating brain conditions
JP6254692B2 (ja)	2013-07-03	2017-12-27	ジアリゾナボードオブリージェンツオンビハーフオブザユニヴァーシティーオブアリゾナ	認知機能不全を治療するための方法
WO2015120316A1 (en)	2014-02-07	2015-08-13	Trevena, Inc.	Crystalline and amorphous forms of a beta-arrestin effector
US9333233B2 (en)	2014-02-25	2016-05-10	Tarix Pharmaceuticals Ltd.	Methods and compositions for the delayed treatment of stroke
US9611293B2 (en)	2014-05-19	2017-04-04	Trevena, Inc.	Synthesis of beta-arrestin effectors
EP3171886A4 (de)	2014-07-21	2018-01-24	The Arizona Board of Regents On Behalf of the University of Arizona	Ang-(1-7)derivat-oligopeptide und verfahren zur verwendung und herstellung davon
US10183055B2 (en)	2014-07-21	2019-01-22	Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
WO2017066552A1 (en) *	2015-10-14	2017-04-20	Tarix Pharmaceuticals Ltd.	Methods and compositions for the treatment of epidermolysis bullosa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3886134A (en) *	1970-03-09	1975-05-27	Morton Norwich Products Inc	Analogues of angiotensin II
US5015629A (en) *	1989-06-26	1991-05-14	University Of Southern California	Tissue repair

1994
- 1994-09-19 DE DE69429450T patent/DE69429450T2/de not_active Expired - Fee Related
- 1994-09-19 AU AU77302/94A patent/AU706333B2/en not_active Ceased
- 1994-09-19 PT PT94928150T patent/PT730465E/pt unknown
- 1994-09-19 EP EP94928150A patent/EP0730465B1/de not_active Expired - Lifetime
- 1994-09-19 JP JP7509853A patent/JPH09502977A/ja not_active Ceased
- 1994-09-19 AT AT94928150T patent/ATE210677T1/de not_active IP Right Cessation
- 1994-09-19 ES ES94928150T patent/ES2168312T3/es not_active Expired - Lifetime
- 1994-09-19 CA CA002172493A patent/CA2172493C/en not_active Expired - Lifetime
- 1994-09-19 DK DK94928150T patent/DK0730465T3/da active
- 1994-09-19 WO PCT/US1994/010503 patent/WO1995008337A1/en active IP Right Grant
- 1994-09-21 ZA ZA947338A patent/ZA947338B/xx unknown
- 1994-11-05 TW TW083110297A patent/TW311088B/zh active
- 1994-11-14 US US08/337,781 patent/US5629292A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US5629292A (en)	1997-05-13
EP0730465A4 (de)	1997-11-12
CA2172493A1 (en)	1995-03-30
TW311088B (de)	1997-07-21
AU7730294A (en)	1995-04-10
DE69429450T2 (de)	2002-07-25
DK0730465T3 (da)	2002-04-08
ZA947338B (en)	1995-05-10
DE69429450D1 (de)	2002-01-24
JPH09502977A (ja)	1997-03-25
PT730465E (pt)	2002-06-28
EP0730465B1 (de)	2001-12-12
CA2172493C (en)	2003-09-16
EP0730465A1 (de)	1996-09-11
ES2168312T3 (es)	2002-06-16
AU706333B2 (en)	1999-06-17
WO1995008337A1 (en)	1995-03-30

Legal Events

Date	Code	Title	Description
2006-06-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE210677T1 (de)	2001-12-15	Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung
MX9703609A (es)	1997-08-30	Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
DE69435301D1 (de)	2010-08-26	Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
ATE309775T1 (de)	2005-12-15	Die verwendung von prostaglandin f analoga zur herstellung von zusammensetzungen für die behandlung von haarausfall.
ATE393831T1 (de)	2008-05-15	Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
DE69430440D1 (de)	2002-05-23	Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten
NO971568D0 (no)	1997-04-04	Analoger av keratinocyttvekstfaktor
ATE383169T1 (de)	2008-01-15	Komponente und zusammensetzungen zur verabreichung von wirkstoffen
AR003641A1 (es)	1998-08-05	Composiciones y metodos para controlar los hongos perjudiciales.
DE59409832D1 (de)	2001-09-20	Pflaster zur behandlung von nagelmykosen
DE60040753D1 (de)	2008-12-18	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
AR018357A1 (es)	2001-11-14	Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos
BR9507730A (pt)	1997-09-23	Uso de formulações em gel como composições de tratamento
IT1247945B (it)	1995-01-05	Agente avente attivita' batteriostatica e battericida
CA2130967A1 (en)	1996-02-27	Long life deodorant composition
NO2019032I1 (no)	2019-07-23	Treosulfan
ES2134237T3 (es)	1999-10-01	Composiciones farmaceuticas que contienen acido ursodesoxicolico.
ES2088128T3 (es)	1996-08-01	Aminosulfonilureas inhibidoras de acat.
DK0613368T3 (da)	1998-01-26	Hudregenererende kosmetisk sammensætning
FR2720938B1 (fr)	1996-08-30	Composition dermato-cosmétologique et son utilisation.
MX9709983A (es)	1998-03-29	El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
ES2065308T1 (es)	1995-02-16	Producto para el moldeado permanente del cabello y nuevos esteres de acido 2-hidroxi-3-mercaptopropionico reductores de la queratina capilar.
DE69931148D1 (de)	2006-06-08	Behandlung von hiv infektionen
EA199800953A1 (ru)	1999-04-29	Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
UA23369A (uk)	1998-08-31	Антисептичний перев`язний матеріал